Published: 4 June 2026
Publications
Quarterly summary of recent safety communications
Published: 4 June 2026
Prescriber Update 47(2): 30
June 2026
The table below is a summary of recent safety communications for
healthcare professionals and consumers. Click on a specific topic to
go to the communication.
| Date |
Communication |
Topic |
| 21/05/2026 |
Alert |
Consumer advisory: Unapproved peptide products health warning
|
| 11/05/2026 |
Dear Healthcare Professional Letter |
Noflam (naproxen) 250 mg Tablets – New Zealand carton containing
either the Norwegian or Dutch blisters (PDF, 1 page, 130
KB) |
| 11/05/2026 |
Dear Healthcare Professional Letter |
Zyprexa Relprevv (olanzapine): Temporary shortage of 405 mg
powder for injection (PDF, 2 pages, 265 KB) |
| 30/04/2026 |
Dear Healthcare Professional Letter |
Utrogestan (progesterone) 100mg capsules – Temporary supply
of overseas product (PDF, 2 pages, 439 KB) |
| 24/04/2026 |
Monitoring |
Further Update – Estradot (estradiol) transdermal patches: reports
of quality and efficacy |
| 03/04/2026 |
Dear Healthcare Professional Letter |
Candesartan Viatris 4mg, 8mg, 16mg and 32mg Tablets – Supply
of French Carton, Foils and Leaflet (PDF, 4 pages, 677 KB)
|
| 05/03/2026 |
Dear Healthcare Professional Letter |
Zypine ODT (Olanzapine) Orodispersible Tablets – Alternative
Registered Foils (PDF, 2 pages, 488 KB) |
Note that sponsors write Dear Healthcare Professional Letters and distribute
them to relevant healthcare professionals. Medsafe publishes copies
of these letters on the
Medsafe website.
